New access system for drugs for public patients announced
Approved new medicines should be available to public patients within 180 days of a HSE cost assessment decision, a conference on access to new drugs has heard.
Original Source
Read the full article at Rte →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.